Gemina Laboratories Ltd. (GLABF)

USD 0.44

(-2.91%)

Long Term Debt Summary of Gemina Laboratories Ltd.

  • Gemina Laboratories Ltd.'s latest annual long term debt in 2024 was 205.98 Thousand CAD , down 0.0% from previous year.
  • Gemina Laboratories Ltd.'s latest quarterly long term debt in 2024 FY was 205.98 Thousand CAD , up 3.86% from previous quarter.
  • Gemina Laboratories Ltd. reported annual long term debt of 198.32 Thousand CAD in 2023, up 3554.36% from previous year.
  • Gemina Laboratories Ltd. reported annual long term debt of 5427.00 CAD in 2022, down -85.57% from previous year.
  • Gemina Laboratories Ltd. reported quarterly long term debt of 205.98 Thousand CAD for 2024 FY, up 3.86% from previous quarter.
  • Gemina Laboratories Ltd. reported quarterly long term debt of 246.04 Thousand CAD for 2024 Q2, down 0.0% from previous quarter.

Annual Long Term Debt Chart of Gemina Laboratories Ltd. (2024 - 2021)

Historical Annual Long Term Debt of Gemina Laboratories Ltd. (2024 - 2021)

Year Long Term Debt Long Term Debt Growth
2024 205.98 Thousand CAD 0.0%
2023 198.32 Thousand CAD 3554.36%
2022 5427.00 CAD -85.57%
2021 37.6 Thousand CAD 0.0%

Peer Long Term Debt Comparison of Gemina Laboratories Ltd.

Name Long Term Debt Long Term Debt Difference
Eiger BioPharmaceuticals, Inc. - USD -Infinity%
Nanobac Pharmaceuticals, Incorporated - USD -Infinity%
SQZ Biotechnologies Company 20.9 Million USD 99.015%
Evofem Biosciences, Inc. 8000.00 USD -2474.775%
Santhera Pharmaceuticals Holding AG 1.75 Million USD 88.266%
Mesoblast Limited 100.29 Million USD 99.795%
Propanc Biopharma, Inc. 58.64 Thousand USD -251.253%
Genus plc 228.2 Million USD 99.91%
VioQuest Pharmaceuticals, Inc. - USD -Infinity%
CNBX Pharmaceuticals Inc. - USD -Infinity%
Marizyme, Inc. 667.12 Thousand USD 69.124%
ContraFect Corporation 2.21 Million USD 90.68%
Nymox Pharmaceutical Corporation - USD -Infinity%
PsyBio Therapeutics Corp. - USD -Infinity%
Sienna Biopharmaceuticals, Inc. - USD -Infinity%
RegeneRx Biopharmaceuticals, Inc. 1.4 Million USD 85.318%
Intellipharmaceutics International Inc. - USD -Infinity%
AXIM Biotechnologies, Inc. 5.42 Million USD 96.204%
MultiCell Technologies, Inc. 36.43 USD -565318.611%
Accustem Sciences Inc. - USD -Infinity%
RVL Pharmaceuticals plc 55.61 Million USD 99.63%
EV Biologics, Inc. - USD -Infinity%
Q BioMed Inc. - USD -Infinity%
Emmaus Life Sciences, Inc. 2.22 Million USD 90.747%
Neon Bloom, Inc. - USD -Infinity%
Mosaic ImmunoEngineering Inc. 1.22 Million USD 83.231%
Biomind Labs Inc. - USD -Infinity%
TetraLogic Pharmaceuticals Corporation - USD -Infinity%
Pharming Group N.V. 166.1 Million USD 99.876%
Oncotelic Therapeutics, Inc. 1.89 Million USD 89.15%
Skye Bioscience, Inc. 171.23 Thousand USD -20.296%
Therapeutic Solutions International, Inc. 5512.00 USD -3636.974%
THC Farmaceuticals, Inc. - USD -Infinity%
Arch Therapeutics, Inc. - USD -Infinity%
IMV Inc. 27.39 Million USD 99.248%
Acro Biomedical Co., Ltd. - USD -Infinity%
Curative Biotechnology, Inc. - USD -Infinity%
GB Sciences, Inc. 322 Thousand USD 36.03%
Alpha Cognition Inc. - USD -Infinity%
HST Global, Inc. - USD -Infinity%
CSL Limited 11.23 Billion USD 99.998%
Halberd Corporation 150 Thousand USD -37.321%
Enzolytics Inc. - USD -Infinity%
Resverlogix Corp. - USD -Infinity%
Affymax, Inc. - USD -Infinity%
SYBLEU INC 300 Thousand USD 31.339%
Nuo Therapeutics, Inc. 164.2 Thousand USD -25.442%
argenx SE 15.35 Million USD 98.658%
MetaStat, Inc. - USD -Infinity%
Northwest Biotherapeutics, Inc. 20.31 Million USD 98.986%
Enzon Pharmaceuticals, Inc. - USD -Infinity%
Arno Therapeutics, Inc. - USD -Infinity%
RespireRx Pharmaceuticals Inc. - USD -Infinity%
GeneThera, Inc. - USD -Infinity%
Inhibitor Therapeutics, Inc. - USD -Infinity%
AVAX Technologies, Inc. - USD -Infinity%
Zenith Capital Corp. 4456.00 USD -4522.576%
Genscript Biotech Corporation 287.12 Million USD 99.928%
Ember Therapeutics, Inc. - USD -Infinity%
Anthera Pharmaceuticals, Inc. - USD -Infinity%
Sigyn Therapeutics, Inc. 126.3 Thousand USD -63.087%
WPD Pharmaceuticals Inc. 229.29 Thousand USD 10.166%
American Oriental Bioengineering, Inc. 554.59 Thousand USD 62.859%
Provectus Biopharmaceuticals, Inc. 25.29 Thousand USD -714.19%
Adynxx, Inc. - USD -Infinity%
Helix BioMedix, Inc. - USD -Infinity%
GlobeStar Therapeutics Corporation - USD -Infinity%
VitaSpring Biomedical Co. Ltd. - USD -Infinity%
Capstone Therapeutics Corp. 8.26 Million USD 97.507%
Cotinga Pharmaceuticals Inc. - USD -Infinity%
BioStem Technologies, Inc. 265.63 Thousand USD 22.457%
ONE Bio Corp. 592.19 Thousand USD 65.217%
Reve Technologies, Inc. 1064.00 USD -19259.211%
Burzynski Research Institute, Inc. - USD -Infinity%
Wesana Health Holdings Inc. - USD -Infinity%
Agentix Corp. - USD -Infinity%
LadRx Corporation - USD -Infinity%
Cell Source, Inc. - USD -Infinity%
ProtoKinetix, Incorporated - USD -Infinity%
Regen BioPharma, Inc. 149.61 Thousand USD -37.676%
Regen BioPharma, Inc. 149.61 Thousand USD -37.676%
NovAccess Global Inc. - USD -Infinity%
Endonovo Therapeutics, Inc. - USD -Infinity%
Itoco Inc. - USD -Infinity%
Rasna Therapeutics, Inc. - USD -Infinity%
Pathfinder Cell Therapy, Inc. - USD -Infinity%
Kadimastem Ltd 229.69 Thousand USD 10.322%
Oncology Pharma Inc. - USD -Infinity%
Institute of Biomedical Research Corp. - USD -Infinity%
CytoDyn Inc. 141 Thousand USD -46.087%
Claritas Pharmaceuticals, Inc. - USD -Infinity%
NDT Pharmaceuticals Inc. - USD -Infinity%
Mobile Lads Corp. - USD -Infinity%
NanoSphere Health Sciences Inc. - USD -Infinity%
Qrons Inc. 80 Thousand USD -157.478%
Alseres Pharmaceuticals, Inc. 7.81 Million USD 97.366%
Advanced Proteome Therapeutics Corporation - USD -Infinity%
Nascent Biotech, Inc. - USD -Infinity%
Rebus Holdings, Inc. - USD -Infinity%
ImmunoCellular Therapeutics, Ltd. 369.04 Thousand USD 44.186%
International Stem Cell Corporation 445 Thousand USD 53.712%
Bioxytran, Inc. - USD -Infinity%
GlobeImmune, Inc. - USD -Infinity%
Predictive Technology Group, Inc. - USD -Infinity%
ProText Mobility, Inc. - USD -Infinity%
Cardax, Inc. - USD -Infinity%
VG Life Sciences Inc. - USD -Infinity%
Kaleido Biosciences, Inc. - USD -Infinity%
Advaxis, Inc. 8.15 Million USD 97.473%
Adhera Therapeutics, Inc. - USD -Infinity%
RenovaCare, Inc. - USD -Infinity%
Regnum Corp. - USD -Infinity%
Innovation Pharmaceuticals Inc. 457 Thousand USD 54.927%
Neutra Corp. - USD -Infinity%
Windtree Therapeutics, Inc. 1.16 Million USD 82.258%
PureTech Health plc 18.25 Million USD 98.871%
Coeptis Therapeutics, Inc. 150 Thousand USD -37.321%
IXICO plc 275 Thousand USD 25.097%
IntelGenx Technologies Corp. 11.83 Million USD 98.26%
Gelesis Holdings, Inc. 26.3 Million USD 99.217%
CSL Limited 11.23 Billion USD 99.998%
Cellectis S.A. 36.21 Million USD 99.431%